Cargando…

A Retrospective Study of thrombolysis with 0.6 mg/kg Recombinant Tissue Plasminogen Activator (rt-PA) in Mild Stroke

We sought to assess the safety, effectiveness and cost of 0.6 mg/kg rt-PA treatment for patients with acute mild stroke and to compare that with 0.9 mg/kg. We retrospectively analyzed consecutive acute ischemic stroke patients who had a NIHSS score ≤5 at admission and who were treated with rt-PA wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jie, Yu, Fei, Liu, Hong, An, Hedi, Xiong, Ran, Huang, Dongya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980662/ https://www.ncbi.nlm.nih.gov/pubmed/27510959 http://dx.doi.org/10.1038/srep31344

Ejemplares similares

Efficacy and safety of short-term high dosage dual antiplatelet therapy after 0.6 mg/kg rt-PA intravenous thrombolysis for acute ischemic stroke
por: Chen, Jing, et al.
Publicado: (2023)

Intravenous thrombolysis with 0.65 mg/kg r-tPA may be optimal for Chinese mild-to-moderate stroke
por: Cui, Yu, et al.
Publicado: (2022)

Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial
por: Koga, Masatoshi, et al.
Publicado: (2020)

Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants
por: Okada, Takashi, et al.
Publicado: (2022)

The Safety and Effectiveness of Low-Dose Recombinant Tissue Plasminogen Activator (0.6 mg/kg) Therapy for Elderly Acute Ischemic Stroke Patients (≥ 80 Years Old) in the Pre-endovascular Era
por: TAKAYANAGI, Shunsaku, et al.
Publicado: (2014)

Is the rapid sequence induction possible with 0.6 mg/kg rocuronium in pediatric patient?
por: Lee, Sang Kyu, et al.
Publicado: (2010)

THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial
por: Koga, Masatoshi, et al.
Publicado: (2014)

Intravenous thrombolysis with rt-PA in stroke: experience of the moroccan stroke unit
por: Chtaou, Naima, et al.
Publicado: (2016)

Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical Trial
por: Koga, Masatoshi, et al.
Publicado: (2023)

Evaluation of intubating conditions with rocuronium 0.6 mg/kg using train of four stimulation in elective surgery
por: Kumar, Nishant, et al.
Publicado: (2022)

The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy
por: Shibata, Soichiro, et al.
Publicado: (2022)

Factors predicting the outcome of intravenous thrombolysis in stroke patients before rt-PA administration
por: Mehrpour, Masoud, et al.
Publicado: (2019)

Successful systemic thrombolysis with rtPA in a patient with history of a life-threatening rtPA-associated orolingual angioedema
por: Pelz, Johann Otto, et al.
Publicado: (2017)

A Case of Oropharyngeal Angioedema Following Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Mechanical Thrombectomy
por: Shirazy, Mohamed, et al.
Publicado: (2019)

Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke
por: Peng, Tao, et al.
Publicado: (2023)

Life-Threatening Anaphylactoid Reaction in an Acute Ischemic Stroke Patient With Intravenous rt-PA Thrombolysis, Followed by Successful Intra-Arterial Thrombolysis
por: Park, In-Serk, et al.
Publicado: (2008)

Efficacy and safety of rt-PA intravenous thrombolysis in patients with wake-up stroke: A meta-analysis
por: Liu, Hongfa, et al.
Publicado: (2022)

Tracheal intubating conditions in elderly patients when train-of-four count is zero after rocuronium 0.6 or 0.9 mg/kg. A secondary analysis
por: Vested, Matias, et al.
Publicado: (2023)

Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis
por: Yang, Hung-Wei, et al.
Publicado: (2012)

Comparative study of intravenous thrombolysis with rt-PA and urokinase for patients with acute cerebral infarction
por: Sun, Fan, et al.
Publicado: (2020)

Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial
por: Chowdary, Pratima, et al.
Publicado: (2023)

Hyperacute ischemic stroke without lesions on diffusion-weighted imaging in a patient treated with rtPA thrombolysis
por: Jing, Zhen, et al.
Publicado: (2014)

Elevated Serum Lactate Dehydrogenase Predicts Unfavorable Outcomes After rt-PA Thrombolysis in Ischemic Stroke Patients
por: Jin, Huijuan, et al.
Publicado: (2022)

Intra-arterial administration of recombinant tissue-type plasminogen activator (rt-PA) causes more intracranial bleeding than does intravenous rt-PA in a transient rat middle cerebral artery occlusion model
por: Crumrine, R Christian, et al.
Publicado: (2011)

Cognitive deficits in acute mild ischemic stroke and TIA and effects of rt‐PA
por: Rosenbaum Halevi, David, et al.
Publicado: (2019)

Clinical Effect of Butylphthalide Combined with Rt-PA Intravenous Thrombolysis in the Treatment of Acute Cerebral Infarction
por: Zhou, Xiangchen, et al.
Publicado: (2022)

Modified electroconvulsive therapy in a resource-challenged setting: Comparison of two doses (0.5 mg/kg and 1 mg/kg) of suxamethonium chloride
por: Aaron, Olurotimi I., et al.
Publicado: (2020)

Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke
por: Huang, Yuyou, et al.
Publicado: (2023)

Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review
por: Lytvyn, Yuliya, et al.
Publicado: (2022)

Validation of a stroke model in rat compatible with rt-PA-induced thrombolysis: new hope for successful translation to the clinic
por: Arkelius, Kajsa, et al.
Publicado: (2020)

Massive pulmonary embolism complicating mild Covid 19 pneumonia: Successful systemic thrombolysis using rt-PA in an elderly patient: A case report
por: Amaqdouf, Saîda, et al.
Publicado: (2021)

Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis
por: HIRANO, Teruyuki
Publicado: (2015)

Thrombolysis with Systemic Recombinant Tissue Plasminogen Activator in Children: A Multicenter Retrospective Study
por: Zengin, Emine, et al.
Publicado: (2021)

Optimization of Catheter Based rtPA Thrombolysis in a Novel In Vitro Clot Model for Intracerebral Hemorrhage
por: Keric, Naureen, et al.
Publicado: (2017)

Retracted: Clinical Effect of Butylphthalide Combined with Rt-PA Intravenous Thrombolysis in the Treatment of Acute Cerebral Infarction
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis in a Patient with Acute Ischemic Stroke Secondary to Aortic Dissection
por: Hong, Keun-Sik, et al.
Publicado: (2009)

Hyperacute thrombolysis with recombinant tissue plasminogen activator of acute ischemic stroke: Feasibility and effectivity from an Indian perspective
por: Sharma, S. R., et al.
Publicado: (2008)

A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial
por: Zinkstok, SM, et al.
Publicado: (2010)

Association Between the Change of Coagulation Parameters and Clinical Prognosis in Acute Ischemic Stroke Patients After Intravenous Thrombolysis With rt-PA
por: Wang, Yu, et al.
Publicado: (2021)

Analysis of influencing factors of early neurological improvement after intravenous rt-PA thrombolysis in acute anterior circulation ischemic stroke
por: Xiufu, Zhang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ene03rs142copi4ludeoiumhci